BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ENO2, HEL-S-279, NSE AND Diagnosis
334 results:

  • 1. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma].
    Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049
    [No Abstract]    [Full Text] [Related]  

  • 2. Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma.
    Gan Y; Kang Y; Zhong R; You J; Chen J; Li L; Chen J; Chen L
    Sci Rep; 2024 Mar; 14(1):7573. PubMed ID: 38555374
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Biomarkers in neuroendocrine neoplasms.
    Zouli C; Zisimopoulou E; Chrisoulidou A
    Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic value of CT and MRI combined with serum LDH, nse, CEA, and MYCN in pediatric neuroblastoma.
    Hao J; Sang J; Xu X; Bao A
    World J Surg Oncol; 2023 Aug; 21(1):251. PubMed ID: 37592273
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Unusual histomorphological spectrum of urinary bladder cancers and their treatment modalities revisited: Our experience with series of five cases.
    Mohanty P; Mohapatra AS; Sabat D; Nayak J
    J Cancer Res Ther; 2023; 19(3):617-623. PubMed ID: 37470584
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma.
    Yue Z; Gao C; Xing T; Zhao W; Duan C; Wang X; Jin M; Su Y
    Pediatr Blood Cancer; 2023 May; 70(5):e30261. PubMed ID: 36815592
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retroperitoneal paraganglioma causing proximal ureteric obstruction in a child: diagnostic conundrum and immunohistochemistry characteristics (case report).
    Atim T; Aiyekomogbon JO
    Pan Afr Med J; 2022; 43():79. PubMed ID: 36591002
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
    Sun Q; Chen Y; Jin Q; Yuan X
    Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The role of methylation profiling in histologically diagnosed neurocytoma: a case series.
    Kalawi AZ; Malicki DM; Abdullaev Z; Pratt DW; Quezado M; Aldape K; Elster JD; Paul MR; Khanna PC; Levy ML; Crawford JR
    J Neurooncol; 2022 Sep; 159(3):725-733. PubMed ID: 35994156
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An
    Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
    Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Small cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
    Lu J; Li Y; Wang J
    Front Cell Infect Microbiol; 2022; 12():916506. PubMed ID: 35909972
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A New Anorectal Melanoma cell Line Derived from a Primary Human Rectal tumor.
    Shinji S; Shichi Y; Yamada T; Takahashi G; Ohta R; Sonoda H; Matsuda A; Yonaga K; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Ueda Y; Sasaki N; Takahashi K; Ohashi R; Ishiwata T; Arai T; Yoshida H
    J Nippon Med Sch; 2022 Aug; 89(4):368-376. PubMed ID: 35082206
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Application of serum markers in medullary thyroid carcinoma].
    Han XD; Lu RQ; Hu HY; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
    [No Abstract]    [Full Text] [Related]  

  • 14. Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?
    Gizhlaryan M; Aghabekyan T; Arakelyan T; Petrosyan M; Iskanyan S; Tamamyan G; Sargsyan L; Papyan R
    Oncology (Williston Park); 2021 Oct; 35(10):665-667. PubMed ID: 34677924
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Values of serum CA125, nse and 24-hour urine VMA in diagnosis and prediction of treatment of paediatric neuroblastoma.
    Li J; Liu X; Chen M; Wang J; Wang X
    Int J Clin Pract; 2021 Dec; 75(12):e14932. PubMed ID: 34606672
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pretreatment Levels of Chromogranin A and Neuron-specific Enolase in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia.
    Kečkéš Š; Palaj J; Waczulíková I; Dyttert D; Mojtová E; Kováč G; Durdík Š
    In Vivo; 2021; 35(5):2863-2868. PubMed ID: 34410979
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Determination of neuron-specific enolase in patients with midgut-type tumour treated with somatostatin analogues.
    Gut P; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Maciejewski A; Komarnicki P; Ruchała M
    Endokrynol Pol; 2021; 72(4):308-318. PubMed ID: 34292567
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Basics for surgeons about the immunohistochemistry role in pancreatic NETs diagnosis.
    Romano L; Giuliani A; Vicentini V; Schietroma M; Carlei F
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2548-2553. PubMed ID: 33829441
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of ependymomas and medulloblastomas located in the posterior cranial fossa: An anatomical and histopathological study.
    Yilmaz T; Aydin Özturk P; Başar İ; Turan Y; Aslanoğlu B; Aydin K; İbiloğlu İ; Tuncer MC
    Arch Ital Biol; 2020 Dec; 158(3-4):74-81. PubMed ID: 33821469
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
    Man S; Yan J; Li J; Cao Y; Hu J; Ma W; Liu J; Zhao Q
    Int J Med Sci; 2021; 18(8):1857-1865. PubMed ID: 33746603
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.